2022 Interim Financial Report

Amoéba announces the publication of its Interim Financial Report for 2022.

Chassieu, October 3, 2022, 5.45 pm, AMOEBA (FR0011051598-ALMIB) – producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, announces today that it has published its Interim Financial Report for 2022. 

AMOEBA’s shareholders are informed that the interim financial report for the 2022 financial year (ending on December 31st, 2022), filed today with the Autorité des Marchés Financiers (AMF), can be found at the company website: 

This report includes: 

• Interim Activity Report 

• Condensed Interim Financial Statements 

• Certification of the person responsible for the interim financial report 

• Statutory Auditors’ Review Report on the interim financial information